| Online-Ressource |
Verfasst von: | Liang, Ting [VerfasserIn]  |
| Liu, Shiru [VerfasserIn]  |
| Dang, Baiyun [VerfasserIn]  |
| Luan, Xiaofa [VerfasserIn]  |
| Guo, Yifan [VerfasserIn]  |
| Steimbach, Raphael R. [VerfasserIn]  |
| Hu, Jiadong [VerfasserIn]  |
| Lu, Long [VerfasserIn]  |
| Yue, Peiyu [VerfasserIn]  |
| Wang, Ruotian [VerfasserIn]  |
| Zheng, Meng [VerfasserIn]  |
| Gao, Jinming [VerfasserIn]  |
| Yin, Xia [VerfasserIn]  |
| Chen, Xin [VerfasserIn]  |
Titel: | Multimechanism biological profiling of tetrahydro-β-carboline analogues as selective HDAC6 inhibitors for the treatment of Alzheimer's disease |
Verf.angabe: | Ting Liang, Shiru Liu, Baiyun Dang, Xiaofa Luan, Yifan Guo, Raphael R. Steimbach, Jiadong Hu, Long Lu, Peiyu Yue, Ruotian Wang, Meng Zheng, Jinming Gao, Xia Yin, Xin Chen |
E-Jahr: | 2024 |
Jahr: | 5 September 2024 |
Umfang: | 18 S. |
Illustrationen: | Illustrationen |
Fussnoten: | Online verfügbar 24 June 2024, Version des Artikel 25 June 2024 ; Gesehen am 08.01.2025 |
Titel Quelle: | Enthalten in: European journal of medicinal chemistry |
Ort Quelle: | Amsterdam [u.a.] : Elsevier Science, 1987 |
Jahr Quelle: | 2024 |
Band/Heft Quelle: | 275(2024) vom: Sept., Artikel-ID 116624, Seite 1-18 |
ISSN Quelle: | 1768-3254 |
Abstract: | With the intensive research on the pathogenesis of Alzheimer's disease (AD), inhibition of HDAC6 appears to be a potential therapeutic approach for AD. In this paper, a series of tetrahydro-β-carboline derivatives with hydroxamic acid group were fast synthesized. Among all, the most potent 15 selectively inhibited HDAC6 with IC50 of 15.2 nM and markedly increased acetylated alpha-tubulin levels. In cellular assay, 15 showed excellent neurotrophic effect by increasing the expression of GAP43 and Beta-3 tubulin markers. Besides, 15 showed neuroprotective effects in PC12 or SH-SY5Y cells against H2O2 and 6-OHDA injury through activation of Nrf2, catalase and Prx II, and significantly reduced H2O2-induced reactive oxygen species (ROS) production. In vivo, 15 significantly attenuated zebrafish anxiety-like behaviour and memory deficits in a SCOP-induced zebrafish model of AD. To sum up, multifunctional 15 might be a good lead to develop novel tetrahydrocarboline-based agents for the treatment of AD. |
DOI: | doi:10.1016/j.ejmech.2024.116624 |
URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
Volltext: https://doi.org/10.1016/j.ejmech.2024.116624 |
| Volltext: https://www.sciencedirect.com/science/article/pii/S022352342400504X |
| DOI: https://doi.org/10.1016/j.ejmech.2024.116624 |
Datenträger: | Online-Ressource |
Sprache: | eng |
Sach-SW: | Alzheimer's disease |
| HDAC6 inhibitor |
| Multimechanism |
| Selectivity |
| Tetrahydrocarboline |
K10plus-PPN: | 1913786013 |
Verknüpfungen: | → Zeitschrift |
Multimechanism biological profiling of tetrahydro-β-carboline analogues as selective HDAC6 inhibitors for the treatment of Alzheimer's disease / Liang, Ting [VerfasserIn]; 5 September 2024 (Online-Ressource)